DXB are now a near 70% chance of taking a drug to market with billions and having exclusive rights with the orphan designation. And thats just FSGS.
and here's people winging about dilution last week....
bring on the covid results!
Ann: Successful $20m Placement to Fund Phase 3 Trials, page-13
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
-0.020(4.44%) |
Mkt cap ! $247.7M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.8¢ | 42.0¢ | $291.8K | 679.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 137256 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 32487 | 3 |
View Market Depth
| Last trade - 10.17am 04/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |